# Pioglitazone in Early Parkinson's Disease

> **NCT01280123** · PHASE2 · COMPLETED · sponsor: **University of Rochester** · enrollment: 210 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01280123
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2015-10-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01280123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01280123, "Pioglitazone in Early Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01280123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*